Clinical Trials in Colorado

Showing 9541-9560 of 13,761 trials

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

NCT01807585

The VeClose pivotal study was a controlled, randomized, prospective, multicenter, pivotal study in which patients with venous reflux in the great saphenous vein (GSV) were treated with either the VenaSeal closure system (VenaSeal SCS) or radiofrequency ablation (RFA) therapy.

Great Saphenous Vein (GSV) With Venous Reflux Disease

Medtronic Endovascular242 participantsStarted Mar 2013

Scottsdale, Arizona, United States • San Diego, California, United States • Greenwood Village, Colorado, United States +7 more locations

COMPLETEDPhase 350 miles

CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)

NCT00675584

Asthma affects about 4 million children in the United States and is a leading cause of hospitalizations and school absenteeism. Continuous wheezing in very young children may develop into asthma. Low doses of inhaled corticosteroids (ICS) are commonly prescribed to treat children with particularly bad wheezing episodes. This study will compare the safety and effectiveness of low doses of ICS taken daily versus higher doses of ICS taken only during respiratory tract illnesses for toddlers with continuous wheezing or coughing illnesses.

Asthma

Milton S. Hershey Medical Center278 participantsStarted Aug 2008

Tucson, Arizona, United States • San Diego, California, United States • Denver, Colorado, United States +2 more locations

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)

Find Trials by Condition in Colorado

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)

Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Pivotal Study to Evaluate the Effectiveness of a Micro-coring Device Treating Moderate to Severe Facial Wrinkles

Temozolomide and Carmustine in Treating Patients With Anaplastic Glioma

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected Subjects